Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani: We Developed a Comprehensive Health System so as not to Exclude any Citizen from the Universal Coverage

 
NNA- The administration and justice committee held a meeting presided by Deputy Robert Ghanem in the presence of Deputy Prime Minister Health Minister Ghassan Hasbani and deputies: Hani Kobaisy, Elie Aoun, Serge Torsarkisian, Atef Majdalani, Ghassan Moukhayber, Nawaf Mousawi, the representatives of Health Ministry Fadi Mosallem and the Ministry of Social Affairs Adnan Naser Eddine, Director General of the National Social Security Fund Dr. Muhammad Karaki, Head of NSSF Diwan Chawki Abou Nassif, the representative of the Ministry of Finance Nahla Boustani, the President of the General Confederation of Lebanese Workers Bechara Asmar.

Ghanem

“This is the eighth meeting of the administration and justice committee to study the so-called visa coverage card; the mandatory universal healthcare coverage suggested by Dr Atef Majdalani and studied by the Health committee. When H.E. Hasbani became Health Minister, he asked that this subject be more comprehensive. A study was conducted to include the majority of the Lebanese citizens,” stated the committee’s president.

Hasbani

“I would like to thank and congratulate the administration and justice committee for discussing the proposal of the law submitted by Deputy Atef Majdalani. The Ministry of Public Health made observations based on a recent study this year on the health coverage or the mandatory universal health care. The detailed study with experts includes many observations made on this subject to develop the system so as not to exclude any citizen from the universal coverage; primary health care, inpatient and outpatient services,” outlined Hasbani.

Majdalani

“I would like to thank my colleague Mr. Robert Ghanem, the president of the administration and justice committee for his help and seriousness in scheduling the meetings of the committee and contribution in the discussions. I thank as well Health Minister Ghassan Hasbani for the amendments of Health Ministry to expand the network of social and health solidarity in the proposal of the law we suggested in 2013,” said Majdalani.
    5
ATC Name B/G Ingredients Dosage Form Price
L04AA06 IMUNOCELL G Mycophenolate mofetil - 500mg 500mg Tablet, film coated 3,791,428 L.L
C09CA04 IBECARD 300- IPS G Irbesartan - 300mg 300mg Tablet, film coated 564,414 L.L
C09CA04 IRBAVEL 300 G Irbesartan - 300mg 300mg Tablet, film coated 564,414 L.L
L01EK01 INLYTA B Axitinib - 5mg 5mg Tablet, film coated 184,486,511 L.L
L01EK01 INLYTA B Axitinib - 1mg 1mg Tablet, film coated 57,595,789 L.L
L01EL01 IMBRUVICA B Ibrutinib - 140mg 140mg Tablet, film coated 194,761,420 L.L
J01MA12 ILFLOX G Levofloxacin - 500mg 500mg Tablet, film coated 587,259 L.L
L01EL01 IMBRUVICA B Ibrutinib - 420mg 420mg Tablet, film coated 584,283,050 L.L
M01AE51 IBUGESIC COLD AND SINUS G Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg Tablet, film coated 154,542 L.L
C09DA04 IBECARD PLUS 150/12.5 G Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 559,294 L.L
C09DA04 IRBAVEL PLUS 150/12.5 G Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 559,294 L.L
C09DA04 IBECARD PLUS 300/12.5 G Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 559,294 L.L
C09DA04 IRBAVEL PLUS 300/12.5 G Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 559,294 L.L
C09DA04 IBECARD PLUS 300/25 G Irbesartan - 300mg, Hydrochlorothiazide - 25mg Tablet, film coated 624,567 L.L
C09DA04 IRBAVEL PLUS 300/25 G Irbesartan - 300mg, Hydrochlorothiazide - 25mg Tablet, film coated 624,567 L.L
N02CC01 IMIGRAN B Sumatriptan (succinate) - 100mg 100mg Tablet, film coated 616,824 L.L
N02CC01 IMIGRAN B Sumatriptan (succinate) - 50mg 50mg Tablet, film coated 378,964 L.L
C08DA01 ISOPTIN B Verapamil (HCl) - 80mg 80mg Tablet, film coated 397,704 L.L
L01EA01 IMATINIB NEAPOLIS G Imatinib - 400mg 400mg Tablet, film coated 36,046,335 L.L
L01EA01 IMATINIB SPC G Imatinib - 400mg 400mg Tablet, film coated 62,161,280 L.L
A10BD09 INCRESYNC B Pioglitazone - 15mg, Alogliptin - 25mg Tablet, film coated 3,897,143 L.L
A10BD09 INCRESYNC B Pioglitazone - 30mg, Alogliptin - 25mg Tablet, film coated 3,897,143 L.L
A10BD11 INAGLIMET G Metformin - 1000mg, Linagliptin - 2.5mg Tablet, film coated 1,670,844 L.L
A10BD11 INAGLIMET G Metformin - 850mg, Linagliptin - 2.5mg Tablet, film coated 1,670,844 L.L
L01EA01 IMATINIB NEAPOLIS G Imatinib - 100mg 100mg Tablet, film coated 26,914,563 L.L
L01EA01 IMATINIB NEAPOLIS G Imatinib - 100mg 100mg Tablet, film coated 13,457,282 L.L
L01EA01 IMATINIB SPC G Imatinib - 100mg 100mg Tablet, film coated 29,473,181 L.L
C08DA01 ISOPTIN SR B Verapamil (HCl) - 240mg 240mg Tablet, film coated, prolonged release 1,128,821 L.L
C01EB17 IVABRADINE ARROW G Ivabradine (HCl) - 5mg 5mg Tablet, film coated, scored 1,323,685 L.L
C01EB17 IVABRADINE ARROW G Ivabradine (HCl) - 7.5mg 7.5mg Tablet, film coated, scored 1,323,685 L.L
    5
Sitemap
© Copyrights reserved to Ministry of Public Health 2025